Prokocimer Philippe 4/A
4/A · Trius Therapeutics Inc · Filed Mar 27, 2012
Insider Transaction Report
Form 4/AAmended
Prokocimer Philippe
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2012-01-13$0.52/sh+4,000$2,080→ 91,778 total(indirect: By Trust) - Exercise/Conversion
Stock Option (right to buy)
2012-01-13−4,000→ 6,244 totalExercise: $0.52Exp: 2018-01-09→ Common Stock (4,000 underlying)
Holdings
- 9,499
Common Stock
Footnotes (3)
- [F1]Amends the end of period holdings that were overstated by 1,687 shares in the original filing. Also includes 8,395 shares that were previously reported as directly held that were previously transferred to Reporting Person's family trust, The Philippe and Maria Prokocimer Family Trust. Includes 693 shares acquired under the TSRX Employee Stock Purchase Plan (the "ESPP") on November 18, 2011.
- [F2]Reflects an 8,395 share reduction in the end of period holdings due to the transfer to Reporting Person's family trust, The Philippe and Maria Prokocimer Family Trust.
- [F3]25% of the shares subject to the 14,244 share option grant vested on 1/1/09, with the remainder vesting monthly thereafter until fully vested on 1/1/12.